EC Number | Application | Comment | Organism |
---|---|---|---|
2.1.1.67 | medicine | individuals with decreased TPMT activity are at high risk of fatal adverse reactions if treated with conventional thiopurine doses | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.1.1.67 | 238G>C | TPMT variant | Homo sapiens |
2.1.1.67 | 460G>A | TPMT variant | Homo sapiens |
2.1.1.67 | 539A>T | TPMT variant | Homo sapiens |
2.1.1.67 | 719A>G | TPMT variant | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.67 | S-adenosyl-L-methionine + a thiopurine | Homo sapiens | - |
S-adenosyl-L-homocysteine + a thiopurine S-methylether | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.67 | Homo sapiens | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.67 | S-adenosyl-L-methionine + 6-mercaptopurine | - |
Homo sapiens | ? | - |
? | |
2.1.1.67 | S-adenosyl-L-methionine + 6-thioguanine | - |
Homo sapiens | ? | - |
? | |
2.1.1.67 | S-adenosyl-L-methionine + a thiopurine | - |
Homo sapiens | S-adenosyl-L-homocysteine + a thiopurine S-methylether | - |
? | |
2.1.1.67 | S-adenosyl-L-methionine + azathioprine | - |
Homo sapiens | ? | - |
? |